Understanding Ocular Graft-Versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach.
Transplant Cell Ther
; 2024 Jul 08.
Article
en En
| MEDLINE
| ID: mdl-38986740
ABSTRACT
Ocular Graft-versus-Host Disease (oGVHD) remains a challenging and potentially devastating complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). It significantly impacts the quality of life of affected survivors, however, is often underrecognized particularly during the early stages. Targeting all providers in the HSCT community who see patients regularly and frequently for their post-allo-HSCT care, this review and opinion piece introduces the basic concepts of ocular surface pathophysiology, dissects the different stages of clinical presentation of oGVHD, explains why the current diagnostic criteria tend to capture the late disease stages, highlights the warning signs of early disease development, in hope to facilitate prompt referral of oGVHD suspects for ocular specialist care. In addition to introducing a comprehensive list of treatment options, this review emphasizes basic therapeutic strategy and options that are safe and effective to be initiated by any care provider. We believe in empowering the patients as well as the care providers beyond disciplinary boundaries, in order to provide the most cohesive and integrated care to our patients in a multidisciplinary approach.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Transplant Cell Ther
Año:
2024
Tipo del documento:
Article
País de afiliación:
Italia